Herbas VPB

Print
EN | LT
LT - Terapijos CD20, terapijos CD22 ir kombinuotos terapijos su CD19 chimerinį antigeno receptorių (CAR) ekspresuojančia ląstele
EN - CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) - EXPRESSING CELL

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 14/725 (2006.01)
C07K 16/28 (2006.01)
C12N 5/0783 (2010.01)
A61K 39/00 (2006.01)
European patent
(11) Number of the document 3280729
(13) Kind of document T
(96) European patent application number 16719611.2
Date of filing the European patent application 2016-04-08
(97) Date of publication of the European application 2018-02-14
(45) Date of publication and mention of the grant of the patent 2022-04-27
(46) Date of publication of the claims translation 2022-08-10
PCT application
(86) Number PCT/US2016/026655
Date 2016-04-08
PCT application publication
(87) Number WO 2016/164731
Date 2016-10-13
Priority applications
(30) Number Date Country code
201562144639 P 2015-04-08 US
201562144615 P 2015-04-08 US
201562144497 P 2015-04-08 US
201562207255 P 2015-08-19 US
201562263423 P 2015-12-04 US
Inventors
(72)
BITTER, Hans , US
BORDEAUX, Jennifer, Mary , US
BRANNETTI, Barbara , CH
BROGDON, Jennifer , US
DAKAPPAGARI, Naveen, Kumar , US
GILL, Saar , US
HIGHFILL, Steven , US
HUANG, Lu , US
JUNE, Carl, H. , US
KIM, Ju, Young , US
LEI, Ming , US
LI, Na , US
LOEW, Andreas , US
ORLANDO, Elena , US
RUELLA, Marco , US
TRAN, Thai , US
ZHANG, Jimin , US
ZHOU, Li , US
Grantee
(73) Novartis AG , Lichtstrasse 35, 4056 Basel, CH
The Trustees of The University of Pennsylvania , 3600 Civic Center Boulevard, 9th Floor, Philadelphia, PA 19104, US
Attorney or representative
(74) Vitalija BANAITIENĖ, UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius, LT
Title
(54) Terapijos CD20, terapijos CD22 ir kombinuotos terapijos su CD19 chimerinį antigeno receptorių (CAR) ekspresuojančia ląstele
  CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) - EXPRESSING CELL
Last renewal fee
Payment date Validity (years) Amount
2025-03-18 10 231.00 EUR
Next renewal fee
2026-04-08